Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

John Cook

Pain Medicine Dakota Dunes, SD Medical Doctor

NPI 1093736779 CMS profile 321310

600 N Sioux Point Rd, Dakota Dunes, SD 57049

Open in the dashboard

General payments

$4,938

208 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, John Cook of Dakota Dunes, SD is reported in the CMS Open Payments database as having received $4,938 across 208 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $14 1
2021 General $982 57
2020 General $1,411 67
2019 General $2,531 83

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Cook
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to John Cook were reported at $0. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year John Cook Pain Medicine median Middle half National median
2019 $2,531 $498 $126–$1,682 $163
2020 $1,411 $284 $80–$910 $114
2021 $982 $399 $112–$1,219 $132
2022 $14 $455 $137–$1,484 $149
2023 $0 $484 $128–$1,495 $160
2024 $0 $498 $131–$1,540 $164
2025 $0 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Abbott Laboratories $1,116 28 payments
  2. Flowonix Medical Incorporated $650 2 payments
  3. Boston Scientific Corporation $334 11 payments
  4. Scilex Pharmaceuticals Inc. $324 19 payments
  5. Amgen Inc. $277 11 payments
  6. Collegium Pharmaceutical, Inc. $197 18 payments
  7. Lilly USA, LLC $175 13 payments
  8. Novartis Pharmaceuticals Corporation $163 11 payments
  9. Pfizer Inc. $162 10 payments
  10. Medtronic USA, Inc. $156 7 payments
  11. Other $1,384 78 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $4,332 207 payments
  2. Entertainment $607 1 payment
Products named General payments · program years 2019–2022
  1. Proclaim Family of SCS IPGs $936 12 payments
  2. Prometra II $650 2 payments
  3. AIMOVIG $439 22 payments
  4. XTAMPZA $197 18 payments
  5. ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH $166 10 payments
  6. ZTLido $158 9 payments
  7. EMGALITY $146 11 payments
  8. REYVOW $140 10 payments
  9. SUPERION $114 2 payments
  10. RELISTOR $110 8 payments
  11. Other $2,092 122 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

208 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record